Cite
Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): study protocol for a phase II study.
MLA
Schmitz-Winnenthal, Friedrich H., et al. “Stem Cell Transplantation for Eradication of Minimal PAncreatic Cancer Persisting after Surgical Excision (STEM PACE Trial, ISRCTN47877138): Study Protocol for a Phase II Study.” BMC Cancer, vol. 14, Mar. 2014, pp. 1–12. EBSCOhost, https://doi.org/10.1186/1471-2407-14-168.
APA
Schmitz-Winnenthal, F. H., Schmidt, T., Lehmann, M., Beckhove, P., Kieser, M., Ho, A. D., Dreger, P., & Büchler, M. W. (2014). Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): study protocol for a phase II study. BMC Cancer, 14, 1–12. https://doi.org/10.1186/1471-2407-14-168
Chicago
Schmitz-Winnenthal, Friedrich H., Thomas Schmidt, Monika Lehmann, Philipp Beckhove, Meinhard Kieser, Anthony D. Ho, Peter Dreger, and Markus W. Büchler. 2014. “Stem Cell Transplantation for Eradication of Minimal PAncreatic Cancer Persisting after Surgical Excision (STEM PACE Trial, ISRCTN47877138): Study Protocol for a Phase II Study.” BMC Cancer 14 (March): 1–12. doi:10.1186/1471-2407-14-168.